Comorbidities
Description:
This web page provides brief recommendations for monitoring patients undergoing buprenorphine treatment using liver function tests, and the proper actions to take if a patient develops hepatitis.
Source:
PCSS Guidance 0
Your rating: None
Tags:
Description:
This document discusses the evidence for buprenorphine treatment of opioid dependent adolescents and young adults. It provides treatment recommendations, and highlights special issues that should be considered when treating this special population.
Source:
Physician Clinical Support System (PCSS) 0
Your rating: None
Tags:
- General information - buprenorphine
- Induction and dosing
- Stabilization and maintenance
- Special populations
- Addiction
- Adolescents
- Comorbidities
- Dependence
- Detoxification
- Diagnosis
- Dosing
- Hepatitis
- Heroin
- HIV/AIDS
- Induction
- Maintenance
- Overdose
- Precautions
- Psychosocial
- Relapse
- Side effects
- Special populations
- Suboxone
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
Description:
Developed by a consensus panel, these guidelines provide treatment recommendations for patients with dual disorders.
Source:
U.S. Department of Health and Human Services, SAMHSA 0
Your rating: None
Tags:
- Screening and diagnosis
- Special populations
- Managing challenging patients
- Addiction
- Assessment
- Behavioral therapy
- Comorbidities
- Complicated patients
- Dependence
- Drug interactions
- Expert panel
- Pharmacology
- Pharmacotherapy
- Pharmacy
- Polysubstance use
- Psychiatric
- Psychosocial
- Referral
- Relapse
- Risk factors
- Screening
- Side effects
- Special populations
- Symptoms
- Tolerance
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
- Need to refer
Description:
This guideline discusses management of psychiatric medications in patients receiving buprenorphine/naloxone, and answers the question "How do I manage medications for co-occurring psychiatric disorders in a patient receiving buprenorphine/naloxone (bup/nx) for the treatment of opioid dependence?"
Source:
PCSSmentor.com 5
Your rating: None Average: 5 (1 vote)
Description:
Although professionals identify distinct personality disorders (anti-social, borderline, schizotypal, et al), some personality disordered individuals may not fit in a particular category and yet may clearly deserve this label.</p>
Although classified as mental disorders they may be classified separately and distinguished from the Axis I Clinical Syndromes for some purposes.
Source:
BehaveNet® 0
Your rating: None
Tags:
Description:
This study examined the efficacy of methadone in relieving cancer pain and also discusses side effects.
Source:
Cochrane Reviews 4.666665
Your rating: None Average: 4.7 (3 votes)
Tags:
Description:
This website offers comprehensive guidelines for treating patients who have substance use disorders.
Source:
American Psychiatric Association (APA), 2006 4.25
Your rating: None Average: 4.3 (4 votes)
Tags:
Description:
Complete overview of substance-induced psychotic disorders.
Source:
Encyclopedia of Mental Disorders 4.5
Your rating: None Average: 4.5 (2 votes)
Tags:
Description:
DSM-IV criteria for substance-induced anxiety disorder.
Source:
BehaveNet® 4
Your rating: None Average: 4 (2 votes)
Tags:
Description:
Defines and lists the diagnostic criteria for substance-induced mood disorder.
Source:
All About Depression TM 5
Your rating: None Average: 5 (2 votes)
- Home
- Training/CME
- Resources
- How-To Guides
- All How-To Guides
- Get Started Prescribing Buprenorphine
- Assess and Treat Patients with Comorbid Health Issues
- Conduct Buprenorphine Induction
- Establish and Manage a Buprenorphine Practice
- Manage Challenging Patients
- Comply with Rules, Regulations, and Recordkeeping
- Understand Insurance and Billing Issues
- Screen for Substance Abuse
- Refer Patients to an Addiction Specialist
- Review: What is Buprenorphine?
- Your Bup Site!

